FDA approves new type of PSA testing methodology

According to a report on the US Food and Drug Administration (FDA) web site, the FDA has just approved the “finger-prick” Sangia Total PSA blood test developed by OPKO Diagnostics. … READ MORE …

Good news and less good news for OPKO Diagnostics

So first the “less good” news … READ MORE …

OPKO Health, OURLab, and the 4Kscore test for prostate cancer risk

According to a media release on the company’s web site, OPKO Health has completed the acquisition of Prost-Data, Inc. (otherwise known to many prostate cancer patients and support group leaders — as well as their urologists — as Jonathon Oppenheimer’s independent uropathology company OURLab). … READ MORE …